UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms

Neuron (Cambridge, Mass.), 2012-02, Vol.73 (4), p.638-652

2012

Link zum Volltext

Verfügbarkeit prüfen

Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology

Nature neuroscience, 2012-08, Vol.15 (8), p.1063-1067

2012

Link zum Volltext

Verfügbarkeit prüfen

TRPA1 is a major oxidant sensor in murine airway sensory neurons

The Journal of clinical investigation, 2008-05, Vol.118 (5), p.1899-1910

2008

Link zum Volltext

Verfügbarkeit prüfen

Bacteria activate sensory neurons that modulate pain and inflammation

Nature (London), 2013-09, Vol.501 (7465), p.52-57

2013

Link zum Volltext

Verfügbarkeit prüfen

Loss of Kv3.1 Tonotopicity and Alterations in cAMP Response Element-Binding Protein Signaling in Central Auditory Neurons of Hearing Impaired Mice

The Journal of neuroscience, 2004-02, Vol.24 (8), p.1936-1940

2004

Link zum Volltext

Verfügbarkeit prüfen

Amino-termini isoforms of the Slack K+ channel, regulated by alternative promoters, differentially modulate rhythmic firing and adaptation

The Journal of physiology, 2008-11, Vol.586 (21), p.5161-5179

2008

Link zum Volltext

Verfügbarkeit prüfen

Modulation of the Kv3.1b Potassium Channel Isoform Adjusts the Fidelity of the Firing Pattern of Auditory Neurons

The Journal of neuroscience, 2003-02, Vol.23 (4), p.1133-1141

2003

Link zum Volltext

Verfügbarkeit prüfen

TRPA1 Mediates the Noxious Effects of Natural Sesquiterpene Deterrents

The Journal of biological chemistry, 2008-08, Vol.283 (35), p.24136-24144

2008

Link zum Volltext

Verfügbarkeit prüfen

Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation

Neuron (Cambridge, Mass.), 2015-07, Vol.87 (2), p.341-354

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Neurology, 2019-04, Vol.92 (15), p.e1724

2019

Link zum Volltext

Verfügbarkeit prüfen

Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases

The FASEB journal, 2009-04, Vol.23 (4), p.1102-1114

2009

Link zum Volltext

Verfügbarkeit prüfen

Localization of the Na+-activated K+ channel Slick in the rat central nervous system

Journal of comparative neurology (1911), 2005-03, Vol.484 (1), p.80-92

2005

Link zum Volltext

Verfügbarkeit prüfen

Regulation of the timing of MNTB neurons by short-term and long-term modulation of potassium channels

Hearing research, 2005-08, Vol.206 (1), p.133-145

2005

Link zum Volltext

Verfügbarkeit prüfen

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1

The New England journal of medicine, 2023-07, Vol.389 (4), p.309-321

2023

Link zum Volltext

Verfügbarkeit prüfen

Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia

Neurogenetics, 2007-04, Vol.8 (2), p.131-135

2007

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer disease neuropathology in a patient previously treated with aducanumab

Acta neuropathologica, 2022-07, Vol.144 (1), p.143-153

2022

Link zum Volltext

Verfügbarkeit prüfen

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Annals of neurology, 2023-03, Vol.93 (3), p.604-614

2023

Link zum Volltext

Verfügbarkeit prüfen

Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab

Alzheimer's & dementia, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

Immune response to vaccines is maintained in patients treated with dimethyl fumarate

Neurology : neuroimmunology & neuroinflammation, 2018-01, Vol.5 (1), p.e409-e409

2018

Link zum Volltext

Verfügbarkeit prüfen

Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease: Developments in clinical trials and cognitive assessment

Alzheimer's & dementia, 2020-12, Vol.16 (S9)

2020

Link zum Volltext

Verfügbarkeit prüfen

Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Neurogenic Inflammation – The Peripheral Nervous System’s Role in Host Defense and Immunopathology

Nature neuroscience, 2012-07, Vol.15 (8), p.1063-1067

2012

Link zum Volltext

Verfügbarkeit prüfen

Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE)

International journal of MS care, 2016-01, Vol.18 (1), p.9-18

2016

Link zum Volltext

Verfügbarkeit prüfen

EMERGE et ENGAGE : premiers résultats des études de phase III sur l’aducanumab dans la maladie d’Alzheimer au stade précoce

Revue neurologique, 2021-04, Vol.177, p.S2-S2

2021

Link zum Volltext

Verfügbarkeit prüfen

P1‐041: 24‐MONTH ANALYSIS OF APOE ε4 CARRIERS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_5), p.P283-P283

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(36)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms

Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology

TRPA1 is a major oxidant sensor in murine airway sensory neurons

Bacteria activate sensory neurons that modulate pain and inflammation

Loss of Kv3.1 Tonotopicity and Alterations in cAMP Response Element-Binding Protein Signaling in Central Auditory Neurons of Hearing Impaired Mice

Amino-termini isoforms of the Slack K+ channel, regulated by alternative promoters, differentially modulate rhythmic firing and adaptation

Modulation of the Kv3.1b Potassium Channel Isoform Adjusts the Fidelity of the Firing Pattern of Auditory Neurons

TRPA1 Mediates the Noxious Effects of Natural Sesquiterpene Deterrents

Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases

Localization of the Na+-activated K+ channel Slick in the rat central nervous system

Regulation of the timing of MNTB neurons by short-term and long-term modulation of potassium channels

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1

Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia

Alzheimer disease neuropathology in a patient previously treated with aducanumab

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab

Immune response to vaccines is maintained in patients treated with dimethyl fumarate

Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease: Developments in clinical trials and cognitive assessment

Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease

Neurogenic Inflammation – The Peripheral Nervous System’s Role in Host Defense and Immunopathology

Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE)

EMERGE et ENGAGE : premiers résultats des études de phase III sur l’aducanumab dans la maladie d’Alzheimer au stade précoce

P1‐041: 24‐MONTH ANALYSIS OF APOE ε4 CARRIERS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB

Suchergebnisse filtern